Vaccine adjuvants : preparation methods and research protocols /
Saved in:
| Imprint: | Totowa, N.J. : Humana Press, 2000. |
|---|---|
| Description: | 1 online resource (x, 342 pages) : illustrations |
| Language: | English |
| Series: | Methods in molecular medicine ; v. 42 Methods in molecular medicine ; v. 42. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11129222 |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | 11129222 | ||
| 006 | m o d | ||
| 007 | cr cnu|||uuuuu | ||
| 008 | 000428s2000 njua ob 001 0 eng d | ||
| 005 | 20240628162326.9 | ||
| 019 | |a 170923324 |a 272404966 |a 320977931 |a 607601026 |a 609216039 |a 642460017 |a 771201878 |a 964890217 |a 967621868 |a 985040241 |a 993980458 |a 994752151 |a 1005745819 |a 1017903143 |a 1045327336 |a 1050735327 |a 1058391109 |a 1078042827 |a 1078825082 |a 1078865312 |a 1081207077 |a 1086814679 |a 1097346321 |a 1109038093 |a 1120894777 |a 1164904491 |a 1166255116 |a 1203632364 |a 1228577401 |a 1229573900 | ||
| 020 | |a 9781592590834 |q (electronic bk.) | ||
| 020 | |a 1592590837 |q (electronic bk.) | ||
| 020 | |a 128082073X | ||
| 020 | |a 9781280820731 | ||
| 020 | |a 9786610820733 | ||
| 020 | |a 6610820732 | ||
| 020 | |z 9780896037359 |q (alk. paper) | ||
| 020 | |z 0896037355 |q (alk. paper) | ||
| 024 | 7 | |a 10.1385/1592590837. |2 doi | |
| 035 | |a (OCoLC)55698114 |z (OCoLC)170923324 |z (OCoLC)272404966 |z (OCoLC)320977931 |z (OCoLC)607601026 |z (OCoLC)609216039 |z (OCoLC)642460017 |z (OCoLC)771201878 |z (OCoLC)964890217 |z (OCoLC)967621868 |z (OCoLC)985040241 |z (OCoLC)993980458 |z (OCoLC)994752151 |z (OCoLC)1005745819 |z (OCoLC)1017903143 |z (OCoLC)1045327336 |z (OCoLC)1050735327 |z (OCoLC)1058391109 |z (OCoLC)1078042827 |z (OCoLC)1078825082 |z (OCoLC)1078865312 |z (OCoLC)1081207077 |z (OCoLC)1086814679 |z (OCoLC)1097346321 |z (OCoLC)1109038093 |z (OCoLC)1120894777 |z (OCoLC)1164904491 |z (OCoLC)1166255116 |z (OCoLC)1203632364 |z (OCoLC)1228577401 |z (OCoLC)1229573900 | ||
| 035 | 9 | |a (OCLCCM-CC)55698114 | |
| 040 | |a YUS |b eng |e pn |c YUS |d OCLCQ |d N$T |d YDXCP |d CUV |d CNTRU |d GW5XE |d IDEBK |d OCLCQ |d CUS |d COO |d OCLCQ |d DAY |d CSU |d OCLCE |d E7B |d OCLCQ |d OCLCO |d OCLCQ |d OCLCF |d OCLCQ |d EUW |d EBLCP |d OCLCQ |d VT2 |d OCLCA |d OTZ |d STF |d OCLCO |d OCLCA |d BUF |d OCLCO |d CASUM |d MERER |d OCLCQ |d U3W |d OCLCO |d OCLCQ |d AU@ |d OCLCO |d OCLCA |d OCLCQ |d OCLCA |d YOU |d CANPU |d OCLCQ |d OCLCO |d U3G |d OCLCQ |d HS0 |d GW5XE |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d INARC |d LIP |d UWK |d LVT |d OCLCQ |d OCLCO | ||
| 042 | |a dlr | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a QR187.3 |b .V33 2000 | |
| 060 | 4 | |a QW 805 |b V1154 2000 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MJCM. |2 bicssc | |
| 245 | 0 | 0 | |a Vaccine adjuvants : |b preparation methods and research protocols / |c edited by Derek T. O'Hagan. |
| 260 | |a Totowa, N.J. : |b Humana Press, |c 2000. | ||
| 300 | |a 1 online resource (x, 342 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Methods in molecular medicine ; |v v. 42 | |
| 500 | |a Source of title; title from title screen. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a An overview of adjuvant use -- Harmful and beneficial activities of immunological adjuvants -- Freund's adjuvants -- Aluminum compounds as vaccine adjuvants -- Poly(lactice-coglycolide) microparticles as vaccine adjuvants -- Poly(methyl methacrylate) nanoparticles as vaccine adjuvants -- Aqueous formulation of adjuvant-active nonionic block copolymers -- Liposomes as immunological adjuvants and vaccine carriers -- Immunopotentiating reconstituted indluezna virosomes (IRIVs) -- Cochleates for induction of mucosal and systemic immune responses -- Virus-like particles as vaccine adjuvants -- The adjuvant MF59: a 10 year perspective -- Preparation of the syntex adjuvant formulation (SAF, SAF-m, SAF-1) -- The ISCOM technology -- QS-21 adjuvant -- MPL Immunostimulant: adjuvant formulations -- Cytokines as vaccine adjuvants: the use of interleukin-2 -- DNA as an adjuvant -- Transcutaneous immunizaation -- Mutant heat-lbile enterotoxins as adjuvants for CTL induction. | |
| 520 | 8 | |a Annotation |b Derek T. O'Hagan and a team of expert vaccinologists and pharmacologists thoroughly describe the preparation, characterization, and evaluation of a wide range of alternative vaccine adjuvants for use in preclinical studies. Each chapter carefully reviews a single adjuvant, and suggests why a specific adjuvant might be preferred for a given antigen, depending on what type of immune response is desired. Alternate adjuvant choices are also presented so that researchers can choose those most efficacious for their specific purpose. Comprehensive and highly practical, Vaccine Adjuvants: Preparation Methods and Research Protocols provides an effective guide to making and using vaccine adjuvants. By closely following directions from the book, today's researchers will be able optimally to induce specific immune responses against different types of antigens and to selectively manipulate the immune response in a favorable way. | |
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 546 | |a English. | ||
| 588 | |a Print version record. | ||
| 650 | 0 | |a Immunological adjuvants. |0 http://id.loc.gov/authorities/subjects/sh85000895 | |
| 650 | 0 | |a Vaccines. |0 http://id.loc.gov/authorities/subjects/sh85141718 | |
| 650 | 2 | |a Vaccines. | |
| 650 | 2 | |a Adjuvants, Immunologic. | |
| 650 | 2 | |a Immunologic Factors. | |
| 650 | 2 | |a Biological Products. | |
| 650 | 2 | |a Complex Mixtures. | |
| 650 | 2 | |a Physiological Effects of Drugs | |
| 650 | 2 | |a Chemicals and Drugs | |
| 650 | 2 | |a Pharmacologic Actions | |
| 650 | 2 | |a Chemical Actions and Uses | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Immunological adjuvants. |2 fast |0 (OCoLC)fst00967992 | |
| 650 | 7 | |a Vaccines. |2 fast |0 (OCoLC)fst01163573 | |
| 650 | 1 | 7 | |a Wetenschappelijke technieken. |2 gtt |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a O'Hagan, Derek T. |0 http://id.loc.gov/authorities/names/n93804460 | |
| 776 | 1 | |t Vaccine adjuvants |w (DLC) 99088373 | |
| 830 | 0 | |a Methods in molecular medicine ; |v v. 42. |0 http://id.loc.gov/authorities/names/n88525800 | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i c56ebddc-d450-5135-a427-cf6ed4929e42 |s 6d162628-2623-52a7-8e88-7bbc63b46a04 |
| 928 | |t Library of Congress classification |a QR187.3 .V33 2000 |l Online |c UC-FullText |u https://link.springer.com/10.1385/1592590837 |z Springer Nature |g ebooks |i 12530705 | ||